Esbriet® (pirfenidone)
for Idiopathic Pulmonary Fibrosis

Esbriet (pirfenidone) is used to treat adults with idiopathic pulmonary fibrosis (IPF), a lung condition that causes inflammation and scarring. Esbriet works by slowing the buildup of scar tissue in the lungs, though its exact mechanism is not fully understood. It has anti-inflammatory, antioxidant, and anti-fibrotic properties.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Idiopathic Pulmonary Fibrosis